In a surprising turn, U.S. President Donald Trump has paused “Project Freedom,” a strategic initiative aimed at safeguarding shipping in the Strait of Hormuz, citing “Great Progress” towards a comprehensive agreement with Iran. This de-escalation signal, coupled with blockbuster earnings from tech giants like AMD and Micron, has fueled a robust market rally, sending the S&P 500 and Nasdaq to new record highs, even as domestic health agencies face controversy over vaccine safety studies.
Hello and welcome to another edition of CNBC's Daily Open, brought to you by Hui Jie from Singapore.
Just days after its grand announcement, U.S. President Donald Trump has put "Project Freedom" on hold, adding another unexpected twist to the complex Middle East conflict. This initiative, designed to ensure the safe passage of ships through the critical Strait of Hormuz, has been temporarily suspended as President Trump declared that "Great Progress has been made toward a Complete and Final Agreement" with Iran.
Meanwhile, the financial markets have been anything but on hold. A relentless tech-fueled rally, spearheaded by chip-related companies, has propelled U.S. benchmarks to unprecedented highs. Investors reacted with optimism to the geopolitical developments, with futures for all three major indexes climbing. This follows a powerful session on Wall Street where the S&P 500 and Nasdaq both achieved new record closes, driven by a wave of stellar earnings reports.
The Shifting Sands of Geopolitics
The Iran conflict remains shrouded in uncertainty, with both Tehran and Washington sending mixed signals regarding a potential diplomatic resolution. Despite recent escalations, including Iran's strike on the UAE and the U.S. sinking Iranian ships, Defence Secretary Hegseth insists that the ceasefire remains "not over." While Washington claims Iran is "defeated," Tehran continues to exert its influence over shipping in the strategic Strait of Hormuz.
Further signaling a potential diplomatic path, Iran's foreign minister is slated to visit China for talks with his counterpart, Wang Yi. This visit, marking the first since the conflict began, precedes President Trump's own upcoming trip to Beijing later this month, highlighting intense international efforts to de-escalate tensions.
Tech Sector's Unstoppable Ascent
The tech sector continues its extraordinary ascent, acting as a primary catalyst for the broader market's strength. Advanced Micro Devices (AMD) shares surged over 16% in extended trading after reporting first-quarter results that significantly surpassed expectations, thanks to an explosion in demand for AI-powered chips.
Server manufacturer Super Micro Computer also saw its shares leap 18% in after-hours trading, buoyed by robust guidance, even though its fiscal third-quarter revenue narrowly missed analyst estimates. This widespread tech optimism also propelled semiconductor memory giant Micron Technology into an elite group, becoming one of the top 10 most valuable U.S. tech companies. Its shares climbed 11%, pushing its market capitalization past an impressive $700 billion for the first time.
While the shadow of the Iran conflict still looms, these positive de-escalatory signals combined with a booming tech sector have significantly boosted investor confidence and risk sentiment – for now, at least, until the next major headline emerges.
A Controversial Move from the FDA
In domestic news, the U.S. Food and Drug Administration (FDA) made headlines by blocking the publication of several studies that supported the safety of Covid and shingles vaccines. This move, confirmed by a Health and Human Services Department spokesperson, is seen as the latest effort by the Trump administration to question established medical science.
Under Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine skeptic, federal health agencies have reportedly softened recommendations for Covid shots, reduced research into vaccine development, and even attempted to revise the childhood immunization schedule. These actions have raised concerns about public health policy and access to vital medical information.
